<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhu JJ</submitter><funding>HHS | National Institutes of Health</funding><funding>NHLBI NIH HHS</funding><funding>National Natural Science Foundation of China</funding><pagination>8271-8276</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5547597</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>114(31)</volume><pubmed_abstract>Vascular endothelial cells (ECs) at arterial branches and curvatures experience disturbed blood flow and induce a quiescent-to-activated phenotypic transition of the adjacent smooth muscle cells (SMCs) and a subsequent smooth muscle hyperplasia. However, the mechanism underlying the flow pattern-specific initiation of EC-to-SMC signaling remains elusive. Our previous study demonstrated that endothelial microRNA-126-3p (miR-126-3p) acts as a key intercellular molecule to increase turnover of the recipient SMCs, and that its release is reduced by atheroprotective laminar shear (12 dynes/cm&lt;sup>2&lt;/sup>) to ECs. Here we provide evidence that atherogenic oscillatory shear (0.5 ± 4 dynes/cm&lt;sup>2&lt;/sup>), but not atheroprotective pulsatile shear (12 ± 4 dynes/cm&lt;sup>2&lt;/sup>), increases the endothelial secretion of nonmembrane-bound miR-126-3p and other microRNAs (miRNAs) via the activation of SNAREs, vesicle-associated membrane protein 3 (VAMP3) and synaptosomal-associated protein 23 (SNAP23). Knockdown of VAMP3 and SNAP23 reduces endothelial secretion of miR-126-3p and miR-200a-3p, as well as the proliferation, migration, and suppression of contractile markers in SMCs caused by EC-coculture. Pharmacological intervention of mammalian target of rapamycin complex 1 in ECs blocks endothelial secretion and EC-to-SMC transfer of miR-126-3p through transcriptional inhibition of VAMP3 and SNAP23. Systemic inhibition of VAMP3 and SNAP23 by rapamycin or periadventitial application of the endocytosis inhibitor dynasore ameliorates the disturbed flow-induced neointimal formation, whereas intraluminal overexpression of SNAP23 aggravates it. Our findings demonstrate the flow-pattern-specificity of SNARE activation and its contribution to the miRNA-mediated EC-SMC communication.</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>VAMP3 and SNAP23 mediate the disturbed flow-induced endothelial microRNA secretion and smooth muscle hyperplasia.</pubmed_title><pmcid>PMC5547597</pmcid><funding_grant_id>81470590</funding_grant_id><funding_grant_id>HL106579</funding_grant_id><funding_grant_id>91539116</funding_grant_id><funding_grant_id>R01 HL108735</funding_grant_id><funding_grant_id>HL108735</funding_grant_id><funding_grant_id>R01 HL106579</funding_grant_id><funding_grant_id>31522022</funding_grant_id><pubmed_authors>Zhao CR</pubmed_authors><pubmed_authors>Li YS</pubmed_authors><pubmed_authors>Huang TS</pubmed_authors><pubmed_authors>Yao WJ</pubmed_authors><pubmed_authors>Wang XF</pubmed_authors><pubmed_authors>Pang W</pubmed_authors><pubmed_authors>Chien S</pubmed_authors><pubmed_authors>Wang KC</pubmed_authors><pubmed_authors>Liu YF</pubmed_authors><pubmed_authors>Zhu JJ</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Zhang YP</pubmed_authors><pubmed_authors>Zhou J</pubmed_authors></additional><is_claimable>false</is_claimable><name>VAMP3 and SNAP23 mediate the disturbed flow-induced endothelial microRNA secretion and smooth muscle hyperplasia.</name><description>Vascular endothelial cells (ECs) at arterial branches and curvatures experience disturbed blood flow and induce a quiescent-to-activated phenotypic transition of the adjacent smooth muscle cells (SMCs) and a subsequent smooth muscle hyperplasia. However, the mechanism underlying the flow pattern-specific initiation of EC-to-SMC signaling remains elusive. Our previous study demonstrated that endothelial microRNA-126-3p (miR-126-3p) acts as a key intercellular molecule to increase turnover of the recipient SMCs, and that its release is reduced by atheroprotective laminar shear (12 dynes/cm&lt;sup>2&lt;/sup>) to ECs. Here we provide evidence that atherogenic oscillatory shear (0.5 ± 4 dynes/cm&lt;sup>2&lt;/sup>), but not atheroprotective pulsatile shear (12 ± 4 dynes/cm&lt;sup>2&lt;/sup>), increases the endothelial secretion of nonmembrane-bound miR-126-3p and other microRNAs (miRNAs) via the activation of SNAREs, vesicle-associated membrane protein 3 (VAMP3) and synaptosomal-associated protein 23 (SNAP23). Knockdown of VAMP3 and SNAP23 reduces endothelial secretion of miR-126-3p and miR-200a-3p, as well as the proliferation, migration, and suppression of contractile markers in SMCs caused by EC-coculture. Pharmacological intervention of mammalian target of rapamycin complex 1 in ECs blocks endothelial secretion and EC-to-SMC transfer of miR-126-3p through transcriptional inhibition of VAMP3 and SNAP23. Systemic inhibition of VAMP3 and SNAP23 by rapamycin or periadventitial application of the endocytosis inhibitor dynasore ameliorates the disturbed flow-induced neointimal formation, whereas intraluminal overexpression of SNAP23 aggravates it. Our findings demonstrate the flow-pattern-specificity of SNARE activation and its contribution to the miRNA-mediated EC-SMC communication.</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Aug</publication><modification>2026-05-06T00:21:06.974Z</modification><creation>2019-03-26T22:59:25Z</creation></dates><accession>S-EPMC5547597</accession><cross_references><pubmed>28716920</pubmed><doi>10.1073/pnas.1700561114</doi></cross_references></HashMap>